Compare IVR & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVR | BVS |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 708.6M | 617.1M |
| IPO Year | N/A | 2016 |
| Metric | IVR | BVS |
|---|---|---|
| Price | $8.33 | $10.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.25 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 2.0M | 408.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 17.80% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $150.63 | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ $6.63 | $29.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.10 | $5.81 |
| 52 Week High | $9.50 | $10.76 |
| Indicator | IVR | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 58.92 |
| Support Level | $8.26 | $8.43 |
| Resistance Level | $8.44 | $10.76 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 65.56 | 49.22 |
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.